Research progress on estrogen and its receptors in occurrence and advance of Crohn's disease

doi:10.16352/j.issn.1001-6325.2022.03.017

Abstract

Abstract: Crohn's disease (CD) is a subtype of inflammatory bowel diseases and may be resulted from endocrine disorders. Estrogen and its receptors exert an important role in the pathogenesis of CD. Studies have revealed that estrogen can down-regulate the expression of inflammatory mediators while estrogen supplementation helps reduce the severity of inflammatory response. The expression of receptors (GPER, ERα and ERβ) also influence local immune responses, and the imbalance of them mediate intestinal inflammation. Nowadays, estrogen and its receptors are expected to become a new rarget in the research of CD.

Key words: Crohn's disease, inflammatory bowel disease, estrogen, receptor, mechanism

CLC Number:

R574

WU Guo-zhi, AN Li-na, LIU Min, WANG Yu-ping, GUO Qing-hong. Research progress on estrogen and its receptors in occurrence and advance of Crohn's disease[J]. Basic & Clinical Medicine, 2022, 42(3): 494-497.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.03.017

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I3/494

References

[1]Mao R, Kurada S, Gordon I, et al. The mesenteric fat and intestinal muscle interface: creeping fat influencing stricture formation in Crohn's disease[J]. Inflamm Bowel Dis, 2019, 25: 421-426.
[2]Thomann A, Reindl W, Wüstenberg T, et al. Aberrant brain structural large-scale connectome in Crohn's disease[J]. Neurogastroenterol Motil, 2019, 31. doi: 10.1111/nmo.13593.
[3]关玉霞, 尤丽丽, 王田田, 等. 炎性肠病患者知觉压力和应对方式与抑郁水平的相关性[J]. 基础医学与临床, 2019, 39: 1623-1626.
[4]陈丹, 李骥, 张鑫垚, 等. 克罗恩病患者维生素D水平与细胞因子的相关性研究[J]. 中华医学杂志, 2020,100: 757-762.
[5]Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from western countries[J]. Gastroenterology, 2018, 155: 1079-1089.
[6]Shah SC, Khalili H, Chen CY, et al. Sex-based differ-ences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region[J]. Aliment Pharmacol Ther, 2019, 49: 904-911.
[7]Kravdal O, Magnus P, Moum B, et al. Association of childbearing with a short-term reduced risk of Crohn disease in mothers[J]. Am J Epidemiol, 2020, 189: 294-304.
[8]Cook LC, Hillhouse AE, Myles MH, et al. The role of estrogen signaling in a mouse model of inflammatory bowel disease: a helicobacter hepaticus model[J]. PLoS One, 2014, 9. Doi: 10.1371/journal.pone.0094209.
[9]Jacenik D, Zielińska M, Michlewska S, et al. Visualiza-tion of estrogen receptors in colons of mice with tnbs-induced Crohn's disease using immunofluorescence[J]. J Vis Exp, 2020. doi: 10.3791/60813.
[10]Van der Giessen J, Van der Woude CJ, Peppelenbosch MP, et al. A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models[J]. Cells, 2019, 8: 261-273.
[11]Liu JM, Yu CP, Chuang HC, et al. Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases[J]. Prostate Cancer Prostatic Dis, 2019, 22: 475-482.
[12]Lahat A, Falach-Malik A, Haj O, et al. Change in bowel habits during menstruation: are IBD patients different?[J]. Therap Adv Gastroenterol, 2020, 13. doi: 10.1177/1756284820929806.
[13]Rolston VS, Boroujerdi L, Long MD, et al. The influence of hormonal fluctuation on inflammatory bowel disease symptom severity-a cross-sectional cohort study[J]. Inflamm Bowel Dis, 2018, 24: 387-393.
[14]Lachowski D, Cortes E, Matellan C, et al. G protein-coupled estrogen receptor regulates actin cytoskeleton dynamics to impair cell polarization[J]. Front Cell Dev Biol, 2020, 8. doi: 10.3389/fcell.2020.592628.
[15]Liu J, Lin G, Fang M, et al. Localization of estrogen receptor ERα, ERβ and GPR30 on myenteric neurons of the gastrointestinal tract and their role in motility[J]. Gen Comp Endocrinol, 2019, 272: 63-75.
[16]Jacenik D, Cygankiewicz AI, Mokrowiecka A, et al. Sex- and age-related estrogen signaling alteration in inflammatory bowel diseases: modulatory role of estrogen receptors[J]. Int J Mol Sci, 2019, 20. doi: 10.3390/ijms20133175.
[17]Linares P, Algaba A, Urzainqui A, et al. Ratio of circulating estrogen receptors beta and alpha (ERβ/ERα) indicates endoscopic activity in patients with Crohn's disease[J]. Dig Dis Sci, 2017, 62: 2744-2754.
[18]Jacenik D, Cygankiewicz AI, Fichna J, et al. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome[J]. Mol Cell Endocrinol, 2018, 471: 89-96.
[19]Zimmerman MA, Ogola BO, Wilkinson MM, et al. Medroxyprogesterone opposes estradiol-induced renal damage in midlife ovariectomized long evans rats[J]. Menopause, 2020, 27: 1411-1419.
[20]Pelekanou V, Kampa M, Kiagiadaki F, et al. Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1[J]. J Leukoc Biol, 2016, 99: 333-347.
[21]Cabas I, Rodenas M, Abellán E, et al. Estrogen signal-ing through the G protein-coupled estrogen receptor regulates granulocyte activation in fish[J]. J Immunol, 2013, 191: 4628-4639.
[22]Xiao L, Luo Y, Tai R, et al. Estrogen receptor β suppresses inflammation and the progression of prostate cancer[J]. Mol Med Rep, 2019, 19: 3555-3563.
[23]Goodman W, Bedoyan S, Havran H, et al. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine[J]. Proc Natl Acad Sci U S A, 2020, 117: 17166-17176.
[24]Goodman W, Havran H, Quereshy H, et al. Estrogen receptor α loss-of-function protects female mice from dss-induced experimental colitis[J]. Cell Mol Gastroenterol Hepatol, 2018, 5: 630-633.
[25]Braniste V, Leveque M, Buisson-Brenac C, et al. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells[J]. J Physiol, 2009, 587: 3317-3328.
[26]Li HX, Chen H, Chen L, et al. Expression of oestrogen receptor beta was negatively correlated with disease activity in patients with Crohn's disease involving the terminal ileum[J]. Steroids, 2019,141: 36-40.